SNDL - Mydecine Innovations Group (MYCOF) Submits Pre-Investigational New Drug Briefing Package to the FDA for MYCO-001
The biotech sector is also presenting exciting opportunities for investors. Many of the best biotech companies have both strong drug candidate pipelines and winning drugs already on the market. The COVID-19 pandemic has also created massive opportunities for biotechnology companies. According to the Centers for Disease Control and Prevention (CDC), cigarette smoking is responsible for […]
For further details see:
Mydecine Innovations Group (MYCOF) Submits Pre-Investigational New Drug Briefing Package to the FDA for MYCO-001